Guangyuyuan
Embrace the essence of wellness with our authentic Chinese herbal medicine and health wine, crafted to enhance your vitality and enrich your life.
Embrace the essence of wellness with our authentic Chinese herbal medicine and health wine, crafted to enhance your vitality and enrich your life.
Guangyuyuan is a niche biotech startup with a history dating back to 1541. The company's core focus lies in the manufacturing and distribution of health wine and traditional Chinese medicine. Their product lineup, which includes Dingkun Dan, Guilingji, Angong Niuhuang Pills, and Niuhuang Qingxin Pills, reflects their commitment to offering genuine Chinese herbal remedies. Notably, the company received a Post-IPO Equity investment on 01 February 2017, with Zhonghe Capital as the participating investor. The GuangYuYuan Chinese Herbal Medicine brand prides itself on embracing the essence of wellness through its authentic Chinese herbal medicine and health wine. The company is dedicated to enriching lives by enhancing vitality, catering primarily to the domestic market. Their operations center on the production and distribution of traditional Chinese medicine products, thereby positioning themselves within the Manufacturing and Pharmaceutical industries. With a rich legacy and a contemporary investment backing, Guangyuyuan presents an enticing proposition for potential investors seeking opportunities within the traditional Chinese medicine market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | Unknown | 1 | Zhonghe Capital | 01 Feb 2017 |
| Post-IPO Equity | CNY5.00M | 8 |
|
25 Nov 1996 |
No recent news or press coverage available for Guangyuyuan.
We care about your data, and we'd love to use cookies make your experience better.